News

Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs...

Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology. The...

The FDA authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus. The FDA issued an emergency use authorization Wednesday for AstraZeneca’s antibody cocktail,...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens,  announced that the National Medical Products Administration (NMPA) of China has granted approval of the company’s monoclonal neutralizing...

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Products Administration (NMPA) has approved the Company’s Clinical Trial Application (CTA) for BI-1206, a First-in-class fully...

ChargePoint Technology, the powder containment and aseptic processing specialist, has accelerated its expansion plans in North America by introducing a newly established team to deliver outstanding customer service in the region. In addition to the company’s existing New Jersey base,...

DoKaSch Temperature Solutions continues to expand its business in Asia. With the dedicated subsidiary DoKaSch Temperature Solutions K.K. in Tokyo and a new service station at Narita International Airport, customers in Japan now have optimal access to the “Opticooler”...